Altimmune, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 20.99M24.27M25.18M17.91M10.19M10.64M3.24M10.74M10.33M5.80M8.19M4.41M0.07M0.43M0.02M
Gross Profit 20.99M24.27M25.18M17.91M10.19M10.64M3.24M10.74M10.33M5.80M8.19M4.41M0.07M0.43M0.02M
Operating items
Depreciation & Amortization - Total 0.46M0.30M0.18M0.15M0.14M0.14M
Research & Development 20.88M21.22M19.51M15.29M9.32M5.13M7.22M18.41M18.46M17.77M49.77M74.54M70.54M65.80M82.23M
Selling, General & Administrative 18.02M14.31M11.63M13.28M10.91M6.22M7.11M8.46M9.77M8.50M13.21M15.41M17.13M18.14M20.97M
Restructuring Costs 2.55M
Other Operating Expenses 5.66M0.78M186.66M-52.32M24.94M1.00M11.37M12.42M
Operating Expenses 44.55M35.99M31.44M28.75M20.38M14.04M14.33M62.78M53.17M27.27M62.98M101.32M87.67M96.36M103.19M
Operating Income -23.55M-11.73M-6.27M-10.84M-10.19M-3.40M-11.09M-52.05M-42.83M-21.46M-54.80M-96.91M-87.74M-95.93M-103.17M
EBIT -23.55M-11.73M-6.27M-10.84M-10.19M-3.40M-11.09M-52.05M-42.83M-21.46M-54.80M-96.91M-87.74M-95.93M-103.17M
Non-operating items
Non Operating Investment Income -5.46M7.14M
Interest & Investment Income 0.01M0.02M0.02M0.00M0.00M0.05M0.23M0.84M0.32M0.20M2.87M7.35M8.07M
Other Non Operating Income -5.46M7.14M0.59M-0.44M0.51M0.30M0.04M-0.01M0.28M0.02M0.02M-0.37M-0.03M0.17M0.05M
Non Operating Income -11.30M7.93M1.54M-0.82M0.30M0.02M0.04M-0.02M-2.49M0.89M0.34M-0.37M2.83M7.48M8.11M
Net income details
EBT -34.85M-3.80M-4.72M-11.66M-9.89M-3.38M-11.09M-52.06M-45.32M-20.58M-54.46M-97.09M-84.91M-88.45M-95.11M
Tax Provisions 0.20M0.06M0.06M0.06M-5.64M-6.15M-0.06M-5.42M-0.20M
Profit After Tax -34.85M-3.80M-4.92M-11.72M-9.96M-3.44M-11.09M-46.43M-39.17M-20.52M-49.04M-97.09M-84.71M-88.45M-95.06M
Income from Continuing Operations -34.85M-3.80M-4.92M-11.72M-9.96M-3.44M-11.09M-46.43M-39.17M-20.52M-49.04M-97.09M-84.71M-88.45M-95.11M
Consolidated Net Income -34.85M-3.80M-4.92M-11.72M-9.96M-3.44M-11.09M-46.43M-39.17M-20.52M-49.04M-97.09M-84.71M-88.45M-95.11M
Income towards Parent Company -34.85M-3.80M-4.92M-11.72M-9.96M-3.44M-11.09M-46.43M-39.17M-20.52M-49.04M-97.09M-84.71M-88.45M-95.11M
Preferred Dividend Payments 0.37M4.93M3.31M0.45M
Net Income towards Common Stockholders -34.85M-3.80M-4.92M-11.72M-9.96M-3.44M-11.46M-51.36M-42.48M-20.97M-49.04M-97.09M-84.71M-88.45M-95.11M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.14M0.16M0.16M0.17M0.21M0.21M0.23M0.74M13.45M15.34M33.07M43.22M49.16M53.73M71.12M
Shares Outstanding (Diluted Average) 57.54M63.99M65.66M25.64M41.28M46.93M53.25M71.00M
EBITDA -23.55M-11.26M-5.96M-10.66M-10.04M-3.26M-17.89M-43.43M-39.63M-20.50M-49.07M-97.09M-84.90M-88.22M-95.03M
Shares Outstanding 46.24M48.24M48.35M52.30M63.60M6.91M0.24M0.61M9.08M15.31M37.14M40.99M49.20M70.68M72.35M
Tax Rate 0.00M0.00M0.00M0.00M0.00M